Long-Term Prevention of Stroke A Modern Comparison of Current Carotid Stenting and Carotid Endarterectomy

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

卷:57

Article

De Rango, Paola¹  Parlani, Gianbattista¹  Verzini, Fabio¹  Giordano, Giuseppe¹  Panuccio, Giuseppe¹  Barbante, Matteo¹  Cao, Piergiorgio² 

[1] Univ Perugia, Hosp SM Misericordia, Unit Vasc & Endovasc Surg, I-06134 Perugia, Italy

[2] S Camillo Forlanini Hosp, Dept Cardiosci, Unit Vasc Surg, Rome, Italy

关键词: angioplasty;    carotid;    endarterectomy;    stenting;    stroke;   

DOI  :  10.1016/j.jacc.2010.09.041

来源: Elsevier

【 摘 要 】

Objectives This study sought to evaluate long-term outcomes of carotid stenting (CAS) versus carotid endarterectomy (CEA) based on physician-guided indications. Background The issue regarding long-term outcome of CAS versus CEA in patients with carotid stenosis is clinically relevant but remains unsettled. Methods Consecutive patients (71% men, mean age 71.3 years) treated by CEA (n = 1,118) or CAS (n = 1,084) after a training phase were reviewed. Selection of treatment was based on better-suitability characteristics (morphology and clinical). Data were adjusted with propensity score analysis and stratified by symptoms, age, and sex. Results Thirty-day stroke/death rates were similar: 2.8% in CAS and 2.0% in CEA (p = 0.27). The risk was higher in symptomatic (3.5%) versus asymptomatic (2.0%) patients (p = 0.04) but without significant difference between CAS and CEA groups. Five-year survival rates were 82.0% in CAS and 87.7% in CEA (p = 0.05). Kaplan-Meier estimates of the composite of any periprocedural stroke/death and ipsilateral stroke at 5 years after the procedure were similar in all patients (4.7% vs. 3.7%; p = 0.4) and the subgroups of symptomatic (8.7% vs. 4.9%; p = 0.7) and asymptomatic (2.5% vs. 3.3%; p = 0.2) patients in CEA versus CAS, respectively. Cox analysis, adjusted by propensity score, identified statin treatment (p = 0.016) and symptomatic disease (p = 0.003) associated with the composite end point. There were no sex-or age-related significant outcome differences. Conclusions When physicians use their clinical judgment to select the appropriate technique for carotid revascularization CAS can offer efficacy and durability comparable to CEA with benefits persisting at 5 years. (J Am Coll Cardiol 2011;57:664-71) (C) 2011 by the American College of Cardiology Foundation

【 授权许可】

Free